One such stock that you may want to consider dropping is AMAG Pharmaceuticals, Inc. AMAG, which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current …
Mr. Ramaswamy Athappan serves as President Commissioner of PT Asuransi Multi Artha Guna Tbk since October 5, 2016. He holds Bachelor of Engineering from Coimbatore Institute of Technology, University of Madras. He served as …
Amarin Corporation plc (AMRN) was a big mover last session ... This continues the recent uptrend for the company as the stock is now up 59% since Oct 10, 2014. The company has seen one positive revision the past one month, while …
Revenue was reported as $532.1 million. AMAG Pharmaceuticals shares have declined 35 percent since the beginning of the year. The stock has climbed nearly 6 percent in the last 12 months. This story was generated by Automated …
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share it with others. That’s right. Send us your changes and we’ll find a home for them. Don’t be shy. Everyone …
(Reuters) - AMAG Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration rejected a single dose use of its hormone injection, Makena, the agency's second rejection in six months. Makena is currently approved and …
The financial guarantee insurance company's shares fell as Puerto Rico's governor warns that the island can't pay its $72 billion public debt. National Bank of Greece, down 31 cents to 97 cents The bank's shares tumbled as the Greek …
Foutz is unfazed. He has more desert miles in these trucks than anyone outside of Ford. Last year, his team drove a largely stock 2017 Raptor in the 49th Baja 1000, covering the 866 miles in just under 36 hours and finishing third. …
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market …
Five analysts surveyed by Zacks expected $166.8 million. AMAG Pharmaceuticals shares have fallen 62 percent since the beginning of the year. The stock has decreased 50 percent in the last 12 months. This story was generated by …